Used in the synthesis of chiral pharmaceuticals, particularly as an intermediate in the production of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure supports the development of drugs targeting central nervous system disorders and cardiovascular diseases. Commonly employed in asymmetric synthesis due to the presence of both amino and hydroxyl functional groups, enabling multiple points for chemical modification. Also utilized in the preparation of beta-adrenergic receptor modulators.